Also known as: Januvia; Glactiv
Sitagliptin Phosphate is the phosphate salt form of sitagliptin, a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. It enhances the incretin system to lower blood glucose in a glucose-dependent manner with minimal hypoglycemia risk. Mediocon Inc manufactures pharmacopoeial-grade Sitagliptin Phosphate at its GMP Aurangabad facility.
| Parameter | Specification |
|---|---|
| CAS Number | 486460-32-6 |
| Molecular Formula | C₁₆H₁₅F₆N₅O · H₃PO₄ |
| Molecular Weight | 523.32 g/mol |
| Grade | IP / BP / EP / USP |
| Category | DPP-4 Inhibitor / Antidiabetic |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |